Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Ịdị ọcha>99.5% EE>99.5%

Nkọwa dị mkpirikpi:

Aha: Boc-3-Hydroxy-1-Adamantyl-D-Glycine

Nọmba: 361442-00-4

Ịdị ọcha:>99.5% (GC) EE:>99.5%

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline Powder

Ọkara nke API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical Boc-3-Hydroxy-1-Adamantyl-D-Glycine
Ụdị okwu (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl) acetic Acid
Nọmba CAS 361442-00-4
Nọmba CAT RF-PI1989
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C17H27NO5
Ibu molekụla 325.40
Ebe esi nri 497.3 ± 20.0 ℃
Njupụta 1.296
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ntụ ntụ kristal na-acha ọcha ma ọ bụ gbanyụọ
Mmiri (KF) <0.50%
Ọnwụ na ihicha <1.00%
Ihe fọdụrụ na mgbanye <0.50%
Otu adịghị ọcha <0.50%
Mgbakọta adịghị ọcha <0.50%
EE > 99.5%
Ịdị ọcha > 99.5%
Spectrum infrared Dabara na Ọdịdị
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ndị na-ahụ maka ọgwụ

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

Ngwa:

Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) bụ etiti API (CAS: 361442-04-8).API (CAS: 361442-04-8)bụ onye na-emechi ihe na-agbanwe agbanwe nke dipeptidyl peptidase-4, nke a na-emepụta maka ọgwụgwọ ụdị ọrịa shuga 2.A na-etinye ya ngwa ngwa mgbe nchịkwa ọnụ gasịrị ma nwee profaịlụ pharmacokinetic dakọtara na otu ugboro kwa ụbọchị.Ọ bụ dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic maka ọgwụgwọ nke ụdị ọrịa shuga 2.DPP-4 inhibitors bụ klaasị nke ogige na-arụ ọrụ site na-emetụta ọrụ nke eke homonụ na a na-akpọ incretins.ỌA na-eji ya na nri na mmega ahụ iji meziwanye njikwa shuga ọbara na ndị okenye nwere ụdị ọrịa shuga mellitus nke 2.Ọ bụghị maka ọgwụgwọ ụdị ọrịa shuga 1.Ọmgbe ụfọdụ, a na-eji ya na ọgwụ ndị ọzọ na-arịa ọrịa shuga.E nwetara ya site na nkwado nke AstraZeneca na Bristol-Myers Squibb Company ma bụrụ nke DPP-IV inhibitor.

Dee ozi gị ebe a ziga anyị ya